Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia

Lignende værker

• The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population
  af: Racil, Zdenek, et al.
  Udgivet: (2010)
• Chronic myelogenous leukemia on target
  af: Némethová, Veronika, et al.
  Udgivet: (2018)
• Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects
  af: Culen, Martin, et al.
  Udgivet: (2016)
• The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients
  af: Belohlavkova, Petra, et al.
  Udgivet: (2018)
• Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients
  af: Fossard, Gaëlle, et al.
  Udgivet: (2016)